In this study, we assessed the contribution of baseline bilirubin level to statistical models for predicting neutropenia based on age, gender, and UGT1A1 genotype among patients receiving first-line irinotecan-based chemotherapy for mCRC. The gene discussed is UGT1A1; the disease is Decreased total neutrophil count.